TaxXel: Taxotere and Xeloda in Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Taxotere New Indication - Gastric Cancer Treatment Registration Trial
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Avastin Trial for Stage IIIB/IV NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2